Alert: Rating Upgrade (3/8/24)-Ligand Pharmaceuticals Inc (NASDAQ: LGND).
Stock Rating Upgrade The Value Trend Rating for Ligand Pharmaceuticals Inc (NASDAQ: LGND) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]